8-K: Flexible Solutions International Announces Q1 2025 Financial Results, Sales Down 19%

Flexible Solutions International reports a 19% decrease in sales for Q1 2025, with a net loss of $277,734, but anticipates a rebound in Q2 and Q3.

Summary

• Flexible Solutions International (FSI) announced its Q1 2025 financial results, reporting a decrease in sales by approximately 19% to $7,473,692 compared to $9,224,872 in Q1 2024.
• The company experienced a net loss of $277,734, or ($0.02) per share, compared to a net income of $457,226, or $0.04 per share, in the same period last year.
• The decline in earnings is attributed to lower sales volume and higher costs of goods, including increased tariffs.
• Non-GAAP operating cash flow for Q1 2025 was $480,268, or $0.04 per share, a decrease from $1,382,874, or $0.11 per share, in Q1 2024.
• The NanoChem division and ENP subsidiary remain the primary revenue and cash flow sources for the company.
• FSI is developing a new agriculture and polymer facility in Panama, with first production expected in Q3 2025.
• The company anticipates that revenue from a new food grade product could begin in Q4 2025 and reach significant levels by the start of 2026, potentially reaching $30 million per year.
• Additional CAPEX of approximately $4 million is estimated for equipment and plant improvements related to the new food grade contract.
• The company expects growth in the ENP division to continue in 2025, particularly in the second half of the year.
• The current tariff on all imports of raw materials from China into the US is between 30% and 58.5% depending on material.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the Q1 results were negative, the company anticipates a rebound and has plans for future growth. The company also has substantial cash on hand and access to a line of credit.

Positives

• The company anticipates a rebound in sales and profitability in Q2 2025.
• FSI has substantial cash on hand in its US subsidiaries and access to a mostly unused line of credit.
• The company is developing a Panama factory to reduce exposure to US tariffs and improve shipping times for international sales.
• The loan used to buy the ENP division will be paid in full in June 2025, freeing up cash flow.
• The company's three-year note for equipment is fully paid in December 2025, freeing up over $2 million in cash flow per year.
• The Florida LLC investment was profitable in Q1 and is expected to return to growth in 2025.

Negatives

• Sales for Q1 2025 were down approximately 19% compared to the same period last year.
• The company reported a net loss of $277,734 in Q1 2025.
• Non-GAAP operating cash flow decreased from $1.38 million in Q1 2024 to $480,268 in Q1 2025.
• Higher tariffs on raw materials from China are negatively impacting costs.
• Some costs related to the Panama factory and the new food grade contract are being expensed, negatively affecting current profits.

Risks

• The company faces risks related to tariffs on raw materials imported from China.
• The success of the new food grade product depends on completing equipment installation and meeting customer pricing expectations.
• Agricultural products in the US are under pressure due to low crop prices and political actions.
• The company's ability to increase sales to existing customers and obtain new customers depends on the success of the Panama factory.
• The company's entry into the drug compounding industry is subject to securing sales and finding partners to reduce risk.

Future Outlook

The company anticipates a rebound in Q2 and Q3 2025, with growth expected in the ENP division in the second half of the year. Revenue from a new food grade product could begin in Q4 2025 and reach significant levels by the start of 2026, potentially reaching $30 million per year.

Management Comments

• Mr. Daniel B. OBrien, CEO, states, 'The customers who adjusted inventory in Q1 returned to normal order patterns in April.'
• Mr. OBrien continues, 'ENP also saw lower revenue, which has rebounded in Q2 and we had lower investment income as a result of reduced ownership in the FL LLC.'

Industry Context

FSI operates in the biodegradable polymers, oil extraction, detergent ingredients, water treatment, crop nutrient availability chemistry, and food and nutrition supplement manufacturing markets. The company's performance is affected by factors such as crop prices, tariffs, and customer inventory adjustments.

Comparison to Industry Standards

• It is difficult to compare FSI directly to industry standards due to its diverse product lines.
• However, companies like BASF and Dow Chemical are major players in the chemical industry with similar product lines.
• Compared to these companies, FSI is a much smaller player with a more focused product portfolio.
• In the food and nutrition supplement manufacturing markets, companies like Nestle and General Mills are major players.
• FSI's entry into this market is relatively new, and it faces competition from established players.

Stakeholder Impact

• Shareholders will be impacted by the decreased sales and net loss in Q1 2025.
• Employees may be impacted by the company's plans to expand into new markets and develop new products.
• Customers may benefit from the company's efforts to reduce costs and improve shipping times.
• Suppliers may be impacted by the company's plans to source raw materials from different locations.

Next Steps

• Complete the installation of new equipment and clean room for the new food grade contract.
• Begin production at the Panama factory in Q3 2025.
• Secure sales and find partners for the GLP-1 drug production line.
• Continue to pay down long-term debt.

Key Dates

Keywords

Flexible Solutions International, Financial Results, Q1 2025, Sales, Net Income, Operating Cash Flow, Tariffs, Panama Factory, Food Grade, ENP Division, NanoChem Division